Release Date: October 12, 2007
Expiration Date: April 12, 2009
Program Overview
The role of the clinician in the prevention, assessment, diagnosis, and treatment of osteoporosis is well established; however, osteoporosis remains underdiagnosed and undertreated. As a result, it is imperative for clinicians in all specialties to screen for and treat osteoporosis to prevent fractures and reduce burden of disease. This program will discuss barriers to providing optimal osteoporosis care and explore how alternative routes of administration can improve outcomes for patients with osteoporosis.
Target Audience
This program is intended for clinical practitioners, clinical investigators and nurses involved in the management of osteoporosis.
Program Objectives
At the conclusion of this program, participants should be able to:
Discuss suboptimal diagnosis and treatment rates for osteoporosis and how inadequate care can impact burden of disease
Recognize the consequences of poor adherence with treatment
Explain the current therapeutic landscape in managing osteoporosis
Analyze how alternative routes of administration can optimize the treatment of osteoporosis and improve therapeutic outcomes for patients
Accreditation
Medical Education Resources Inc. is accredited by the Accreditation Council
for Continuing Medical Education (ACCME) to sponsor continuing education for physicians.
Medical Education Resources is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
This CE activity provides 1.5 contact hours. Provider approval expires April 12, 2009.
Provider approved by the California Board of Registered Nursing, Provider #CEP 12299, for 1.5 contact hours.
Credit Designation Segment
Medical Education Resources, Inc. designates this educational activity for a
maximum of 1.5 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This CE activity provides 1.5 contact hours. Provider approval expires April 12, 2009.
Provider approved by the California Board of Registered Nursing, Provider #CEP 12299, for 1.5 contact hours.
Printer settings may vary. Please use landscape layout option.
Faculty
Chairperson - John P. Bilezikian, MD, FACP, MACE Professor of Medicine and Pharmacology
College of Physicians & Surgeons, Columbia University
Chief, Division of Endocrinology
Director, Metabolic Bone Disease Program
Columbia University Medical Center
New York, New York
E. Michael Lewiecki, MD, FACP Clinical Assistant Professor of Medicine
University of New Mexico School of Medicine
Director, New Mexico Clinical Research & Osteoporosis Center
Albuquerque, New Mexico
Paul D. Miller, MD, FACP Clinical Professor of Medicine
University of Colorado Health Sciences Center
Denver, Colorado
Medical Director, Colorado Center for Bone Research
Lakewood, Colorado
